Methods and compositions for alphavirus replicons

US8961995B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-8961995-B2
Application numberUS-201313789215-A
CountryUS
Kind codeB2
Filing dateMar 7, 2013
Priority dateSep 20, 2012
Publication dateFeb 24, 2015
Grant dateFeb 24, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides alphavirus replicons and methods of their use in producing heterologous protein.

First claim

Opening claim text (preview).

What is claimed is: 1. A recombinant replicon nucleic acid comprising: a) a nucleic acid sequence encoding a first alphavirus 5′ untranslated region (5′ UTR) and a 51 nucleotide conserved sequence element (51 -nt CSE); b) a nucleic acid sequence encoding alphavirus nonstructural proteins nsP1, nsP2, nsP3 and nsP4; c) a nucleic acid sequence encoding an alphavirus subgenornic promoter; d) a nucleic acid sequence encoding a second alphavirus 5′ untranslated region (5′ UTR) and…

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US8961995B2 cover?
The present invention provides alphavirus replicons and methods of their use in producing heterologous protein.
Who is the assignee on this patent?
Uab Research Foundation
What technology area does this patent fall under?
Primary CPC classification C12N15/86. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).